IndraLab
Statements
SCN5A inhibits flecainide. 1 / 1
|
1
reach
"We observed that SCN5A blocking dibenzazepines, but not the cardiac specific inhibitor flecainide, also enhanced killing of intracellular M.bovis BCG (Fig XREF_FIG), with no adverse cytotoxic effects (Supplementary FigS5), suggesting that SCN5A might be the molecular target of CBZ on macrophages."